Association Between MiR-202, MiR-211, and MiR-1238 Gene Polymorphisms and Risk of Vitiligo

Overview

Journal Arch Dermatol Res

Specialty Dermatology

Date 2024 Apr 10

PMID 38597990

Authors

Mahdieh Jafari Shahroudi

Mahnaz Rezaei

Mehdi Mirzaeipour

Mohsen Saravani

Hossein Shahraki-Ghadimi

Sara Arab

Affiliations

Soon will be listed here.

Abstract

Vitiligo, as a common pigment defect in the skin, hair, and mucous membranes, results from the destruction of melanocytes. Recent investigations have shown that miRNA dysregulation contributes in the pathogenesis of vitiligo. Therefore, in this research, our aim is to explore the relationship between miR-202 rs12355840, miR-211 rs8039189, and miR-1238 rs12973308 polymorphisms and susceptibility to vitiligo. A total number of 136 vitiligo patients and 129 healthy individuals as a control group were included in this research. The salting out approach was implemented to extraction genomic DNA. The genetic polymorphisms of miR-202 rs12355840, miR-211 rs8039189, and miR-1238 rs12973308 were determined using PCR-RFLP approach. The findings revealed that miR-202 rs12355840 polymorphism under codominant (CT and TT genotypes), dominant, recessive, overdominant, and also allelic models is correlated with increased risk of vitiligo. In addition, codominant, dominant, overdominant, as well as allelic models of miR-211 rs8039189 polymorphism decrease risk of vitiligo. No significant relationship was observed between the miR-1238 rs12973308 polymorphism and susceptibility to vitiligo. The miR-211 rs8039189 polymorphism may serve a protective effect on vitiligo development and miR-202 rs12355840 polymorphism may act as a risk factor for vitiligo susceptibility.

Citing Articles

A comprehensive outline of the role of non-coding RNAs in vitiligo.

Feghahati F, Ghafouri-Fard S Biochem Biophys Rep. 2025; 41:101916.

PMID: 39881955 PMC: 11774809. DOI: 10.1016/j.bbrep.2025.101916.

Skin Disorders and Osteoporosis: Unraveling the Interplay Between Vitamin D, Microbiota, and Epigenetics Within the Skin-Bone Axis.

Papa V, Li Pomi F, Minciullo P, Borgia F, Gangemi S Int J Mol Sci. 2025; 26(1.

PMID: 39796035 PMC: 11720247. DOI: 10.3390/ijms26010179.

References

Farag A, Shoeib M, Labeeb A, Sleem A, Khallaf H, Khalifa A . Human beta-defensin 1 circulating level and gene polymorphism in non-segmental vitiligo Egyptian patients. An Bras Dermatol. 2022; 98(2):181-188. PMC: 9984704. DOI: 10.1016/j.abd.2022.04.002. View

Oliveira-Caramez M, Veiga-Castelli L, Souza A, Cardili R, Courtin D, Floria-Santos M . Evidence for Epistatic Interaction between and in the Pathogenesis of Nonsegmental Vitiligo. Cells. 2023; 12(4). PMC: 9954564. DOI: 10.3390/cells12040630. View

Kim S, Kwon H, Jeong K, Shin M, Lee M . Association between exonic polymorphisms of human leukocyte antigen-G gene and non-segmental vitiligo in the Korean population. Indian J Dermatol Venereol Leprol. 2022; 88(6):749-754. DOI: 10.25259/IJDVL_219_2021. View

Kussainova A, Kassym L, Bekenova N, Akhmetova A, Glushkova N, Kussainov A . Gene polymorphisms and serum levels of BDNF and CRH in vitiligo patients. PLoS One. 2022; 17(7):e0271719. PMC: 9337645. DOI: 10.1371/journal.pone.0271719. View

Czajkowski R, Mecinska-Jundzill K . Current aspects of vitiligo genetics. Postepy Dermatol Alergol. 2014; 31(4):247-55. PMC: 4171675. DOI: 10.5114/pdia.2014.43497. View

Spritz R, Santorico S . The Genetic Basis of Vitiligo. J Invest Dermatol. 2020; 141(2):265-273. DOI: 10.1016/j.jid.2020.06.004. View

Liu B, Xie Y, Wu Z . Identification of Candidate Genes and Pathways in Nonsegmental Vitiligo Using Integrated Bioinformatics Methods. Dermatology. 2020; 237(3):464-472. DOI: 10.1159/000511893. View

Marchioro H, Silva de Castro C, Fava V, Sakiyama P, Dellatorre G, Miot H . Update on the pathogenesis of vitiligo. An Bras Dermatol. 2022; 97(4):478-490. PMC: 9263675. DOI: 10.1016/j.abd.2021.09.008. View

Yagi H, Nomura T, Nakamura K, Yamazaki S, Kitawaki T, Hori S . Crucial role of FOXP3 in the development and function of human CD25+CD4+ regulatory T cells. Int Immunol. 2004; 16(11):1643-56. DOI: 10.1093/intimm/dxh165. View

10.

Jahan P, Tippisetty S, Komaravalli P . FOXP3 is a promising and potential candidate gene in generalised vitiligo susceptibility. Front Genet. 2015; 6:249. PMC: 4510412. DOI: 10.3389/fgene.2015.00249. View

11.

Kingo K, Aunin E, Karelson M, Ratsep R, Silm H, Vasar E . Expressional changes in the intracellular melanogenesis pathways and their possible role in the pathogenesis of vitiligo. J Dermatol Sci. 2008; 52(1):39-46. DOI: 10.1016/j.jdermsci.2008.03.013. View

12.

Singh S, Singh U, Pandey S . Serum concentration of IL-6, IL-2, TNF-α, and IFNγ in Vitiligo patients. Indian J Dermatol. 2012; 57(1):12-4. PMC: 3312648. DOI: 10.4103/0019-5154.92668. View

13.

Miniati A, Weng Z, Zhang B, Therianou A, Vasiadi M, Nicolaidou E . Stimulated human melanocytes express and release interleukin-8, which is inhibited by luteolin: relevance to early vitiligo. Clin Exp Dermatol. 2013; 39(1):54-7. PMC: 4285432. DOI: 10.1111/ced.12164. View

14.

Desai K, Kumar H, Naveen S, Somanna P . Vitiligo: Correlation with Cytokine Profiles and its Role in Novel Therapeutic Strategies: A Case-Control Study. Indian Dermatol Online J. 2023; 14(3):361-365. PMC: 10231705. DOI: 10.4103/idoj.idoj_6_23. View

15.

Richmond J, Frisoli M, Harris J . Innate immune mechanisms in vitiligo: danger from within. Curr Opin Immunol. 2013; 25(6):676-82. PMC: 3935321. DOI: 10.1016/j.coi.2013.10.010. View

16.

Benzekri L, Gauthier Y . Clinical markers of vitiligo activity. J Am Acad Dermatol. 2017; 76(5):856-862. DOI: 10.1016/j.jaad.2016.12.040. View

17.

Dwivedi M, Laddha N, Shah K, Shah B, Begum R . Involvement of interferon-gamma genetic variants and intercellular adhesion molecule-1 in onset and progression of generalized vitiligo. J Interferon Cytokine Res. 2013; 33(11):646-59. PMC: 3814581. DOI: 10.1089/jir.2012.0171. View

18.

Ratsep R, Kingo K, Karelson M, Reimann E, Raud K, Silm H . Gene expression study of IL10 family genes in vitiligo skin biopsies, peripheral blood mononuclear cells and sera. Br J Dermatol. 2008; 159(6):1275-81. DOI: 10.1111/j.1365-2133.2008.08785.x. View

19.

Xuan Y, Yang Y, Xiang L, Zhang C . The Role of Oxidative Stress in the Pathogenesis of Vitiligo: A Culprit for Melanocyte Death. Oxid Med Cell Longev. 2022; 2022:8498472. PMC: 8800607. DOI: 10.1155/2022/8498472. View

20.

Sravani P, Babu N, Gopal K, Rao G, Rao A, Moorthy B . Determination of oxidative stress in vitiligo by measuring superoxide dismutase and catalase levels in vitiliginous and non-vitiliginous skin. Indian J Dermatol Venereol Leprol. 2009; 75(3):268-71. DOI: 10.4103/0378-6323.48427. View